rs61729608
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_012431.3(SEMA3E):c.1722A>T(p.Gly574=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000898 in 1,613,334 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0049 ( 6 hom., cov: 32)
Exomes 𝑓: 0.00049 ( 4 hom. )
Consequence
SEMA3E
NM_012431.3 synonymous
NM_012431.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0130
Genes affected
SEMA3E (HGNC:10727): (semaphorin 3E) Semaphorins are a large family of conserved secreted and membrane associated proteins which possess a semaphorin (Sema) domain and a PSI domain (found in plexins, semaphorins and integrins) in the N-terminal extracellular portion. Based on sequence and structural similarities, semaphorins are put into eight classes: invertebrates contain classes 1 and 2, viruses have class V, and vertebrates contain classes 3-7. Semaphorins serve as axon guidance ligands via multimeric receptor complexes, some (if not all) containing plexin proteins. This gene encodes a class 4 semaphorin. This gene encodes a class 3 semaphorin. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.5).
BP6
Variant 7-83386996-T-A is Benign according to our data. Variant chr7-83386996-T-A is described in ClinVar as [Benign]. Clinvar id is 240862.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-83386996-T-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.013 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00485 (739/152280) while in subpopulation AFR AF= 0.0167 (694/41570). AF 95% confidence interval is 0.0157. There are 6 homozygotes in gnomad4. There are 343 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 739 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SEMA3E | NM_012431.3 | c.1722A>T | p.Gly574= | synonymous_variant | 15/17 | ENST00000643230.2 | NP_036563.1 | |
SEMA3E | NM_001178129.2 | c.1542A>T | p.Gly514= | synonymous_variant | 15/17 | NP_001171600.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SEMA3E | ENST00000643230.2 | c.1722A>T | p.Gly574= | synonymous_variant | 15/17 | NM_012431.3 | ENSP00000496491 | P1 | ||
SEMA3E | ENST00000642232.1 | c.1722A>T | p.Gly574= | synonymous_variant | 15/17 | ENSP00000494064 | ||||
SEMA3E | ENST00000643441.1 | n.1707A>T | non_coding_transcript_exon_variant | 15/17 |
Frequencies
GnomAD3 genomes AF: 0.00486 AC: 739AN: 152162Hom.: 6 Cov.: 32
GnomAD3 genomes
AF:
AC:
739
AN:
152162
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00121 AC: 302AN: 250568Hom.: 3 AF XY: 0.000908 AC XY: 123AN XY: 135466
GnomAD3 exomes
AF:
AC:
302
AN:
250568
Hom.:
AF XY:
AC XY:
123
AN XY:
135466
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000486 AC: 710AN: 1461054Hom.: 4 Cov.: 30 AF XY: 0.000428 AC XY: 311AN XY: 726814
GnomAD4 exome
AF:
AC:
710
AN:
1461054
Hom.:
Cov.:
30
AF XY:
AC XY:
311
AN XY:
726814
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00485 AC: 739AN: 152280Hom.: 6 Cov.: 32 AF XY: 0.00461 AC XY: 343AN XY: 74466
GnomAD4 genome
AF:
AC:
739
AN:
152280
Hom.:
Cov.:
32
AF XY:
AC XY:
343
AN XY:
74466
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 12, 2020 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
CHARGE syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at